About AVT
Browse Articles
Customer Services

Browse Articles

Additional files for manuscripts published before Volume 14 Issue 6 can be found via the abstract link.

Articles published electronically ahead of print and our archive from Volume 4 Issue 1 to Volume 20 Issue 2 can be found below. Articles published earlier will be made available as soon as possible. If you require an article that cannot be found below, please contact the Editorial Office.

Currently showing:   
Displaying 1900 results:


Correction: Recent trends in early stage response to combination antiretroviral therapy in Australia

Hamish McManus, Jennifer F Hoy, Ian Woolley, Mark A Boyd, Mark D Kelly, Brian Mulhall, Norman J Roth, Kathy Petoumenos, Matthew G Law, the Australian HIV Observational Database

Antiviral Therapy 2015; 20:255

Case report

Management of multidrug-resistant CMV infection in immunocompromised patients: case report of a heart-transplant recipient and review of the literature

Claire Deback, Sonia Burrel, Shaïda Varnous, Guislaine Carcelain, Françoise Conan, Zaïna Aït-Arkoub, Brigitte Autran, Iradj Gandjbakhch, Henri Agut, David Boutolleau

Antiviral Therapy 2015; 20:249-254

Short communication

Lack of the NS5B S282T mutation in HCV isolates from liver tissue of treatment-naive patients with HCV genotype-1b infection

Sergio Maimone, Gianluca Tripodi, Cristina Musolino, Irene Cacciola, Teresa Pollicino, Giovanni Raimondo

Antiviral Therapy 2015; 20:245-247

Original article

Adiponectin and interleukin-6, but not adipose tissue, are associated with worse neurocognitive function in HIV-infected men

Jordan E Lake, Quynh T Vo, Lisa P Jacobson, Ned Sacktor, Eric N Miller, Wendy S Post, James T Becker, Frank J Palella, Ann Ragin, Eileen Martin, Cynthia A Munro, Todd T Brown

Antiviral Therapy 2015; 20:235-244

Original article

Lopinavir/ritonavir plus lamivudine and abacavir or zidovudine dose ratios for paediatric fixed-dose combinations

Naïm Bouazza, Frantz Foissac, Floris Fauchet, David Burger, Jean-René Kiechel, Jean-Marc Treluyer, Edmund V Capparelli, Marc Lallemant, Saïk Urien

Antiviral Therapy 2015; 20:225-233

Original article

Treatment of pegylated interferon-α2a in chronic hepatitis B patients demonstrating a spontaneous decline in HBV DNA after acute exacerbation

Qingxian Cai, Fengjuan Chen, Xiaoqiong Shao, Xiaohong Zhang, Zhixin Zhao, Zhiliang Gao

Antiviral Therapy 2015; 20:217-224

Original article

Cost-effectiveness of boceprevir co-administration versus pegylated interferon-α2b and ribavirin only for patients with hepatitis C genotype 1 in Singapore

Yock Young Dan, Shannon A Ferrante, Elamin H Elbasha, Tun-Ying Hsu

Antiviral Therapy 2015; 20:209-216

Original article

Naturally occurring dominant drug resistance mutations occur infrequently in the setting of recently acquired hepatitis C

Tanya L Applegate, Silvana Gaudieri, Anne Plauzolles, Abha Chopra, Jason Grebely, Michaela Lucas, Margaret Hellard, Fabio Luciani, Gregory J Dore, Gail V Matthews

Antiviral Therapy 2015; 20:199-208

Original article

Epidemiological and clinical features of hepatitis delta in HBsAg-positive patients by HIV status

Laura A Nicolini, Lucia Taramasso, Irene Schiavetti, Edoardo G Giannini, Andrea Beltrame, Marcello Feasi, Giovanni Cassola, Alessandro Grasso, Valentina Bartolacci, Laura Sticchi, Antonino Picciotto, Claudio Viscoli, the Ligurian HBV Study Group

Antiviral Therapy 2015; 20:193-197

Original article

Non-invasive fibrosis assessment predicts sustained virological response to telaprevir with pegylated interferon and ribavirin for chronic hepatitis C

Eiichi Ogawa, Norihiro Furusyo, Motohiro Shimizu, Takeshi Ihara, Takeo Hayashi, Yuji Harada, Kazuhiro Toyoda, Masayuki Murata, Jun Hayashi

Antiviral Therapy 2015; 20:185-192

Copyright © Nucleus Global 2015. Part of Nucleus Global.
Design and Technology by Nucleus Global
Company registration No. 321 0712 (England & Wales). Registered Office address: Admiral House 76-78 Old Street, London EC1V 9AZ.